Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Peter King M.D.
Professor of Neurology
Close
E-mail
pking@uab.edu
Links
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Peter King M.D.
Professor of Neurology
Positions
Senior Scientist
,
Neuro-Oncology
,
O'Neal Comprehensive Cancer Center
Professor (P)
,
Neurology
,
School of Medicine
2004 -
Director
,
Neurology
,
School of Medicine
2004 -
Senior Scientist (C)
,
Center for Glial Biology in Medicine
,
Academic Joint Departments
2006 -
Scientist (C)
,
Comprehensive Neuroscience Center
,
General Clinical Research Center
2009 -
Scientist (C)
,
Center for Cardiovascular Biology (Retired Org)
,
Medicine - Cardiovascular Disease
2010 -
Co-Director
,
Comprehensive Neuroscience Center
,
General Clinical Research Center
2012 -
Professor (S)
,
Cell, Developmental and Integrative Biology (CDIB)
,
Academic Joint Departments
2012 -
Senior Scientist (C)
,
Center for Exercise Medicine
,
Cell, Developmental and Integrative Biology (CDIB)
2014 -
Senior Scientist (C)
,
Civitan International Research Center
,
Academic Joint Departments
2017 -
Senior Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
2019 -
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2014
Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: Implications for amyotrophic lateral sclerosis
.
Journal of Biological Chemistry
. 289:31792-31804.
2014
2002
Porphyria presenting with bilateral radial motor neuropathy: Evidence of a novel gene mutation
.
Neurology
. 58:1118-1121.
2002
2000
Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization
.
Gene
. 242:125-131.
2000
2000
RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay.
.
Nucleic Acids Research
. 28.
2000
Research
Principal Investigator On
FGF23: A Novel Biomarker in ALS and More
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2019 - 2021
Smad Signaling in Skeletal Muscle as a Biomarker of Disease Progression in ALS
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2016 - 2021
Molecular Signatures of Amyotrophic Lateral Sclerosis in Skeletal Muscle
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2013 - 2015
Private Grant
awarded by
QUESTCOR PHARMACEUTICALS, INC.
2013 - 2015
The Role of HuR in Mutant SOD1 Dysregulation of VEGF mRNA Processing
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2008 - 2014
Investigator On
Smad8 is a Driver of Duchenne Muscular Dystrophy Pathology Via MyomiR Repression
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2020 - 2025
Smad8 in Dystrophic Muscle Disease & Its Role in MicroRNA Regulation & Disease Progression
awarded by
KAUL PEDIATRIC RESEARCH INSTITUTE
2019 - 2021
MiR-486 is an Epigenetic Regulator of the Duchenne Muscular Dystrophy
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2020 - 2021
Effects of Myristoylated Alanine-Rich C-Kinase Substrate on Microglial Activation
awarded by
American Brain Tumor Association
2020
Centers of Research Translation (CoRT)
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
2012 - 2017
Centers of Research Translation (CoRT) - Project 3
awarded by
National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
2012 - 2017
UAB Research and Education Program in Neurology, Neurosurgery, and Neuropathology
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2012 - 2017
The Role of the Terminal Complement Pathway in ALS
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2013 - 2016
Negative Impact of RNA Destabilizer Tristetraprolin on Glioma Growth
awarded by
National Cancer Institute/NIH/DHHS
2009 - 2014
Dysregulation of VEGF RNA Stability in Amyotrophic Lateral Sclerosis
awarded by
National Institute of Neurological Disorders and Stroke/NIH/DHHS
2008 - 2014
Background
Education And Training
UAB Hospital, Postdoctoral Fellowship
Doctor of Medicine,
Duke University
1985
University Hospitals Case Medical Center, Internship
1986
Duke University Medical Center, Residency
1989
University Hospitals Case Medical Center, Residency
1987
Cleveland Clinic Foundation, Postdoctoral Fellowship
1992
Duke University Medical Center, Postdoctoral Fellowship
1991
Contact
Full Name
Peter
King